Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine multimodal analgesia in total knee arthroplasty
ChiCTR2100048551Phase 4Recruiting
- Sponsor
- Xinxiang Central Hospital
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postoperative pain (2 arms), sponsored by Xinxiang Central Hospital. Primary endpoints: PCIA press times, Sufentanil total dosage and 4 more. Started Jul 2020; status: recruiting.
02
Drugs
esketamine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2100048551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048551.